Hem › Multipelt myelom › Washington
Kliniska studier för Multipelt myelom i Washington
30 studier för Multipelt myelom söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Study Site 103, Tacoma
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07582432A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Research Site, Puyallup
- Research Site, Seattle
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07391657A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- University of Washington, Seattle
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT04973605A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- NorthWest Medical Specialties, PLLC, Tacoma
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07518186A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
- University of Washington, Seattle
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06500884Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
- Northwest Medical Specialties, PLLC, Tacoma
RekryterarFas 4
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07609940A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- NorthWest Medical Specialties, PLLC, Tacoma
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05552222A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Optum Care Washington, Everett
- American Oncology Network Vista Oncology Division / Physician partner associate, Olympia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07477587TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Northwest Medical Specialties, Bonney Lake
- Northwest Medical Specialties, Federal Way
- Northwest Medical Specialties, Gig Harbor
- och 4 fler
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT02693535Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Fred Hutchinson Cancer Research Center, Seattle
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT07648264Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07181941Collection of Tissue Samples for Cancer Research
- Fred Hutchinson, Seattle
RekryterarObservationsstudie
2 Months · Alla kön · Uppdaterad 16 sep. 2026 · NCT00900198Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Fred Hutchinson Cancer Center, Seattle
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT06297226A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Northwest Medical Specialties Tacoma /ID# 272506, Tacoma
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT06953960Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT04566328A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- Northwest Medical Specialties, Tacoma
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT05651932AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Edmonds
- Research Site, Seattle
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT05850234Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Research Site, Puyallup
- Research Site, Seattle
- Research Site, Seattle
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 14 aug. 2026 · NCT07764978Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Fred Hutch Cancer Center, Seattle
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 juli 2026 · NCT02343042A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Fred Hutchinson Cancer Center. /ID# 267940, Seattle
- Northwest Medical Specialties Tacoma /ID# 267117, Tacoma
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT05650632A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- VA Puget Sound Health Care System, Seattle
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 8 juli 2026 · NCT05137054Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Harrison Medical Center, Bremerton
- och 15 fler
RekryterarFas 3
Alla åldrar · Alla kön · Uppdaterad 10 juni 2026 · NCT05561387Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
- Fred Hutchinson Cancer Center, Seattle
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 19 maj 2026 · NCT06433947Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Swedish Medical Center - Seattle /ID# 268052, Seattle
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 12 maj 2026 · NCT06896916A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- GSK Investigational Site, Puyallup
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 apr. 2026 · NCT06679101Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
- Swedish Cancer Institute, Seattle
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2026 · NCT03761108A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- Swedish Medical Center, Seattle
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 18 mars 2026 · NCT06153251PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
- University of Washington, Seattle
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2025 · NCT05956457Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
- University of Washington, Seattle
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 11 dec. 2024 · NCT05053607Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma
- All4Cure, Seattle
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 3 maj 2024 · NCT06149910Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.